Our Compounding

Therapeutic Category:

Antineoplastic Agent, Antimetabolite, Purine

Key Ingredients:

Mercaptopurine - It is a purine antagonist , inhibits DNA and RNA synthesis ; acts as false metabolite and is incorporated into DNA and RNA, eventually inhibiting their synthesis; specific for S phase of cell cycle.

Formulation Strength:

Mercaptopurine Suspension 25mg/ml

PEDIATRIC ORAL

• Maintenance treatment of acute lymphoblastic leukemia (ALL)
• Acute promyelocytic leukemia (APL)
• Autoimmune hepatitis
• Inflammatory bowel disease ( eg, crohn disease, ulcerative colitis

Should not be administered with meals
Preferably on an empty stomach ( 1 hour before or 2 hours after meals ).
Shake well for atleast 30 second.